News

2019: January is National Glaucoma Awareness Month

IMMEDIATE RELEASE  

                                                                                                                                                                                    For more information:

                                                                                                                                                                 Prevent Blindness Northeast Region

                                                                                                                                                                                                Priscilla Kelangi

                                                                                                                                                                                      Phone: (312)-363-6037

                                                                                                                                                                         [email protected]

                 Increase in Glaucoma Cases Projected to Continue for Decades to Come

 

      – Prevent Blindness Northeast Region Marks January’s National Glaucoma Awareness

               Month by Offering Information and Resources for Patients and Caregivers —

 

Boston, MA (Dec. 28, 2018) – Today, nearly three million people ages 40 and older have glaucoma, according to the Prevent Blindness report, “Future of Vision: Forecasting the Prevalence and Costs of Vision Problems.” Those numbers are projected to increase steadily as more baby boomers move into retirement.  In the early stages, glaucoma has no symptoms, no noticeable vision loss or pain, which is why it is called the “sneak thief of sight.” By the time symptoms start to appear, some permanent damage to the eye has usually occurred.  Glaucoma is a leading cause of blindness.

 

January has been declared as National Glaucoma Awareness Month by Prevent Blindness Northeast Region and other leading eye health groups, in an effort to educate the public on the disease, including risk factors and treatment options.  Prevent Blindness Northeast Region offers a dedicated web page providing patients and their caregivers with additional free information at https://www.preventblindness.org/glaucoma.

 

Unfortunately there is currently no cure for glaucoma., however, promising new treatment research is underway.  Through early detection, access to care, and by diligently following your eye doctor’s treatment plan, progressive vision loss from glaucoma can be significantly lessened.

 

According to the American Academy of Ophthalmology (AAO), the eye constantly makes aqueous humor, the clear liquid inside the front part of the eye that nourishes it and keeps it inflated. As new aqueous flows into the eye, the same amount should drain out. If the drainage angle is not working properly, fluid builds up. Pressure inside the eye rises, damaging the optic nerve, which sends information from the eyes to the brain. When glaucoma damages the optic nerve, patches of vision, usually peripheral vision, are lost permanently.

 

Age, race, family and medical history, are all factors that increase the chances of developing glaucoma. In fact, individuals aged 60 and older are at higher risk. For African-Americans, this risk begins even earlier – those age 40 and over are up to five times more likely to have glaucoma. Hispanics are also at increased risk for glaucoma as they age. Those of Asian and Native American descent are at increased risk for angle-closure glaucoma, caused by a rapid or sudden increase in pressure inside the eye, called intraocular pressure.

 

In support of Glaucoma Awareness Month, Prevent Blindness and Prevent Blindness Northeast Region have partnered with Santen Inc., a U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a global company focused exclusively on ophthalmology, on an educational campaign to raise awareness of this disease.

 

The AAO’s EyeCare America program provides eye care at no out-of-pocket cost to medically underserved seniors age 65 and older, and glaucoma exams to those at increased risk. For more information, visit https://www.aao.org/eyecare-america

For more information on glaucoma, or other financial assistance programs, including Medicare coverage, please contact Prevent Blindness Northeast Region at 312-363-6037 or visit www.childrensvisionmassachusetts.org.

 

 

About Prevent Blindness Northeast Region and Children’s Vision Massachusetts

Prevent Blindness Northeast Region is part of Prevent Blindness, the nation’s leading volunteer eye health and safety organization, serving the states of Maine, Massachusetts, New Hampshire, Rhode Island and Vermont.  Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screenings, community and patient service programs and research.  These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America.  For more information, or to make a contribution to the sight-saving fund, call 1-800-331-2020. Or, visit us on the Web at preventblindness.org or facebook.com/preventblindness

Children’s Vision Massachusetts, supported by Prevent Blindness, is a seventy member coalition of families, professionals from multiple disciplines and affiliations, whose mission is to facilitate the development of a state-wide plan to improve the visual health of children in Massachusetts. To achieve this, the coalition is working to raise awareness and create systems to assure that every child has a vision screening, eye exam, and ongoing treatment if diagnosed with a vision condition.

To join our efforts use #kidsvision #eyehealth #eyesoncapitolhill and spread the word about Children’s Vision Massachusetts. You can also follow us on FacebookTwitterInstagram and LinkedIn

 

About Santen

As a global specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries. With scientific knowledge and organizational capabilities nurtured over a nearly 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. For more information, please visit Santen websites www.SantenUSA.com (United States) and www.Santen.com (global).

 

###